NCT04865133View on ClinicalTrials.gov

Efficacy and Safety of COVID-19 Vaccine in Cancer Patients

CompletedOBSERVATIONAL

Enrollment

89

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

September 8, 2022

Study Completion Date

September 8, 2022

Conditions

COVID-19 InfectionMalignant Solid Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Electronic Health Record Review

Medical record reviewed

Trial Locations (1)

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04865133 - Efficacy and Safety of COVID-19 Vaccine in Cancer Patients | Biotech Hunter | Biotech Hunter